Markus Bürgle
Wilex (Germany)(DE)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Blood Coagulation and Thrombosis Mechanisms, Peptidase Inhibition and Analysis, Chemical Synthesis and Analysis, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → The urokinase plasminogen activator system as a novel target for tumour therapy(2000)108 cited
- → Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides(1997)65 cited
- → Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics(2002)42 cited
- → A Novel Type of Bifunctional Inhibitor Directed against Proteolytic Activity and Receptor/Ligand Interaction(2000)39 cited
- → Cyclo19,31[D-Cys19]-uPA19-31 Is a Potent Competitive Antagonist of the Interaction of Urokinase-Type Plasminogen Activator with Its Receptor (CD87)(2001)32 cited
- → Immunological and Functional Analyses of the Extracellular Domain of Human Tissue Factor(1998)29 cited
- → The Urokinase Receptor (uPAR, CD87) as a Target for Tumor Therapy: uPA-Silica Particles (SP-uPA) as a New Tool for Assessing Synthetic Peptides to interfere with uPA/uPA-Receptor Interaction(2003)7 cited
- → uPA-Silica-Particles (SP-uPA): A Novel Analytical System to Investigate uPA-uPAR Interaction and to Test Synthetic uPAR Antagonists as Potential Cancer Therapeutics(2002)5 cited
- The urokinase-type plasminogen activator (uPA) system - A new target for tumor therapy(2002)
- → Peptidic Inhibitors for Protein-Protein Interactions at Cell Surfaces(2001)1 cited